Lv1
30 积分 2023-11-30 加入
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer
2个月前
已完结
Inflammatory breast cancer biomarkers and biology
2个月前
已完结
Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis
2个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
2个月前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
